Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
---|---|---|---|---|
21922 | Difelikefalin HCl | 2413256-25-2 | ≧98.0% | |
Difelikefalin, also known CR-845; MR-13A-9; MR-13A9, is a novel and potent kappa opio | ||||
20296 | Ecopipam hydrochloride ( SCH-39166 ) | 190133-94-9 | ≧98.0% | |
Ecopipam HCl is a Selective Dopamine Receptor D1/D5 Antagonist used in the treatment | ||||
20302 | VAS3947 | 869853-70-3 | ≧98.0% | |
VAS3947 is a selective inhibitor of NADPH oxidase activity in low micromolar concentr | ||||
20306 | SRI-37330 HCl | 2322245-49-6 | ≧98.0% | |
SRI-37330 hydrochloride is a novel inhibitor of TXNIP expression,and dose-dependently | ||||
20318 | Zotizalkib ( TPX-0131 ) | 2648641-36-3 | ≧98.0% | |
TPX-0131 is a next-generation ALK inhibitor drug candidate currently being evaluated | ||||
20369 | Sunvozertinib ( DZD 9008 ) | 2370013-12-8 | ≧98.0% | |
Sunvozertinib, also known as DZD9008, is an oral, potent, irreversible, and selective | ||||
822221 | IACS-13909 | 2160546-07-4 | ≧98.0% | |
IACS-13909 is a specific and potent allosteric inhibitor of SHP2, that suppresses sig | ||||
171462 | MRTX0902 | 2654743-22-1 | ≧98.0% | |
MRTX0902is a potent SOS1 inhibitor which can be used for the therapeutic intervention | ||||
171652 | EZM0414 | 2411748-50-8 | ≧98.0% | |
EZM0414 is a potent, selective, and orally bioavailable inhibitor of SETD2. | ||||
122622 | CNS004 | 695205-24-4 | ≧98.0% | |
CNS004 is a novel compound that potentiates NMDA receptor currents based on glutamate | ||||
52014 | NXY-059 ( Disufenton Sodium ) | 168021-79-2 | ≧98.0% | |
NXY-059 ( Disufenton Sodium ) is a disulfonyl derivative of phenyl-tert-butyl nitrone | ||||
232251 | Brepocitinib ( PF-06700841 ) | 1883299-62-4 | ≧98.0% | |
Brepocitinib is a potential first-in-class dual, selective inhibitor of TYK2 and JAK1 |
Overnight Delivery
Fast & Safe Delivery Worldwide
Safety and Security
Intimate Service
Copyright 2015-2022 武汉永璨生物科技有限公司 版权所有 | 鄂ICP备17005301号-1